Clear Street’s Tevogen Bio Holdings TVGN Stock Holding History

Clear Street’s Portfolio TVGN Stock Details TVGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-12	Closed	-$6.68K	–	851
2023 Q4	$6.68K	Buy	+12	New	+$6.58K	﹤0.01%	422
2023 Q3	–	Sell	-8	Closed	-$4.21K	–	1320
2023 Q2	$4.21K	Buy	+8	New	+$4.28K	﹤0.01%	846
2023 Q1	–	Sell	-505	Closed	-$261K	–	1274
2022 Q4	$261K	Buy	+505	New	+$258K	﹤0.01%	116
2022 Q3	–	Sell	-35	Closed	-$17K	–	1245
2022 Q2	$17K	Buy	+35	New	+$17.5K	﹤0.01%	437

Other funds holding TVGN

PGA

Portland Global Advisors Portland, Maine $938M AUM 13.22% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Clear Street's TVGN Position: Q1 2024 in Review

Clear Street sold out of Tevogen Bio Holdings (TVGN) in Q1 2024, closing a stake of 12 shares — an estimated $6.68K sold.

Clear Street first reported a position in TVGN in Q2 2022 and held it in 4 quarters. The position peaked at $261K in Q4 2022. 5 funds tracked by Wall St. Rank hold TVGN as of Q1 2024.

Clear Street reported no remaining Tevogen Bio Holdings position as of Q1 2024 after selling out during the quarter.
Clear Street sold 12 Tevogen Bio Holdings shares in Q1 2024, an estimated $6.68K.
Clear Street first reported a position in Tevogen Bio Holdings in Q2 2022 and held it in 4 quarters.
Clear Street's Tevogen Bio Holdings position peaked at $261K in Q4 2022.
5 funds tracked by Wall St. Rank held Tevogen Bio Holdings as of Q1 2024.

Based on Clear Street's 13F filing for Q1 2024, filed 13 May 2024.